Independent role of myo-inositol in weight reduction in a polycystic ovarian syndrome patient: A case report

Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder characterised by insulin resistance, obesity, and menstrual irregularities. Myo-inositol and metformin are frequently used for metabolic correction; however, the independent effect of myo-inositol on anthropometric outcomes remains unclear. This case report describes a 27-year-old female with PCOS who underwent sequential treatment with inositol-based regimens and metformin monotherapy. Weight reduction and improvement in body mass index were observed only during treatment phases containing inositol, whereas no anthropometric change occurred during metformin monotherapy despite equal duration. These findings suggest a potential independent contribution of myo-inositol to weight reduction. Although limited by single-patient observation, this case highlights the need for further controlled studies exploring mechanistic and clinical effects of inositol in PCOS management.

Authors

Institutions

Publication Details

Journal
Indian Journal of Physiology and Pharmacology
Published
2026-11-16
DOI
https://doi.org/10.25259/ijpp_416_2025
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Independent role of myo-inositol in weight reduction in a polycystic ovarian syndrome patient: A case report

Anita Basavaraj, Ganesh Satyadeo Pentewar, Sagarika Basavaraj, Sanjana Basavaraj
Indian Journal of Physiology and Pharmacology
Ovarian function and disorders
article

Independent role of myo-inositol in weight reduction in a polycystic ovarian syndrome patient: A case report

Anita Basavaraj, Ganesh Satyadeo Pentewar, Sagarika Basavaraj, Sanjana Basavaraj
article en

Abstract

Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder characterised by insulin resistance, obesity, and menstrual irregularities. Myo-inositol and metformin are frequently used for metabolic correction; however, the independent effect of myo-inositol on anthropometric outcomes remains unclear. This case report describes a 27-year-old female with PCOS who underwent sequential treatment with inositol-based regimens and metformin monotherapy. Weight reduction and improvement in body mass index were observed only during treatment phases containing inositol, whereas no anthropometric change occurred during metformin monotherapy despite equal duration. These findings suggest a potential independent contribution of myo-inositol to weight reduction. Although limited by single-patient observation, this case highlights the need for further controlled studies exploring mechanistic and clinical effects of inositol in PCOS management.

Indian Journal of Physiology and PharmacologyVol. 0
B. J. Medical College & Sassoon Hospital (IN), Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN), Maharashtra Institute of Medical Education and Research (IN)
Good health and well-being
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon